PerkinElmer Q3 Revenues up 12 Percent, Beat Analyst Estimates on Top and Bottom Line | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that revenues during the third quarter increased 13 percent year over year as the Human Health segment grew 24 percent.

The company reported revenues of $509.6 million for the three months ended Sept. 30, up from $452.9 million a year ago, surpassing the consensus Wall Street estimate of $505.5 million. Human Health revenues rose to $257.2 million, up from $206.6 million, while Environmental Health revenues grew 2 percent to $252.4 million from $246.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.